Protective effects of mitochondria‐targeted antioxidants and statins on cholesterolinduced osteoarthritis
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The contribution of metabolic factors on the severity of osteoarthritis (OA) is not fully appreciated. This study aimed to define the effects of hyper cholesterolemia on the progression of OA. A polipoprotein E‐deficient (ApoE −/− ) mice and rats with diet‐induced hypercholesterolemia (DIHC) rats were used to explore the effects of hyper cholesterolemia on the progression of OA. Both models exhibited OA‐like changes, characterized primarily by a loss of proteoglycans, collagen and aggrecan degradation, osteophyte formation, changes to subchondral bone architecture, and cartilage degradation. Surgical destabilization of the knees resulted in a dramatic increase of degradative OA symptoms in animals fed a high‐cholesterol diet compared with controls. Clinically relevant doses of free cholesterol resulted in mitochondrial dysfunction, overproduction of reactive oxygen species (ROS), and increased expression of degenerative and hypertrophic markers in chondrocytes and breakdown of the cartilage matrix. We showed that the severity of diet‐induced OA changes could be attenuated by treatment with both atorvastatin and a mitochondrial targeting antioxidant. The protective effects of the mitochondrial targeting antioxidant were associated with suppression of oxidative damage to chondrocytes and restoration of extracellular matrix homeostasis of the articular chondrocytes. In summary, our data show that hypercholesterolemia precipitates OA progression by mitochondrial dysfunction in chondrocytes, in part by increasing ROS production and apoptosis. By addressing the mitochondrial dysfunction using antioxidants, we were able attenuate the OA progression in our animal models. This approach may form the basis for novel treatment options for this OA risk group in humans.—Farnaghi, S., Prasadam, I., Cai, G., Friis, T., Du, Z., Crawford, R., Mao, X., Xiao, Y. Protective effects of mitochondria‐targeted antioxidants and statins on cholesterolinduced osteoarthritis. FASEB J. 31, 356–367 (2017) www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mitochondrial dysfunction in rodent models of arthritis could be reduced via treatment with statins or antioxidants (for example, Coenzyme Q10 or omega-3)87,88”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [87]
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., & Dikalov, S. I. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 737
Reactive oxygen species and superoxide dismutases: Role in joint diseases
Afonso, V., Champy, R., Mitrovic, D., Collin, P., & Lomri, A. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.02.002 · Cited by 642
Metabolic syndrome meets osteoarthritis
Zhuo, Q., Yang, W., Chen, J., & Wang, Y. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.135 · Cited by 588
Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction
Yang, S., Kim, J., Ryu, J.-H., Oh, H., Chun, C.-H., Kim, B. J., Min, B. H., & Chun, J.-S. (2010) · Nature Medicine · doi:10.1038/nm.2153 · Cited by 527
Oxygen and reactive oxygen species in cartilage degradation: friends or foes?
Henrotin, Y., Kurz, B., & Aigner, T. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.04.002 · Cited by 487
The gut microbiota and its relationship to diet and obesity: New insights
Clarke, S. F., Murphy, E. F., Nilaweera, K., Ross, P. R., Shanahan, F., O’Toole, P. W., & Cotter, P. D. (2012) · Gut Microbes · doi:10.4161/gmic.20168 · Cited by 458
Brandt, K. D., Fife, R. S., Braunstein, E. M., & Katz, B. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341106 · Cited by 298
Collins, K. H., Paul, H. A., Reimer, R. A., Seerattan, R. A., Hart, D. A., & Herzog, W. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.014 · Cited by 250
Research works printed but not linked: 2
- Villalvilla A., 2013, Lipidtransport andmetabolism inhealthy andosteoarthritic cartilage, Int. J. Mol. Sci, 14
- Gierman L. M., 2013, Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden. CETP mice: a translational model for atherosclerosis, Ann. Rheum. Dis, 73, 921, 10.1136/annrheumdis-2013-203248 · DOI
Cited by
Items 101–122 of 122
Hubungan Peningkatan Kadar Kolesterol dengan Derajat Keparahan Osteoarthritis
Fredianto, M. (2017) · Mutiara Medika: Jurnal Kedokteran dan Kesehatan · doi:10.18196/mmjkk.v17i1.3681
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
Zonova, E. V. (2021) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2021-2-126-131
Diet-induced hypercholesterolemia in small laboratory animal models
Herfel, T. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00029-8
Zeliger, H. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91890-9.00006-4
Takenami, L. I., Filha, A. M. S. G., Bomfim, E. S., Lagares, L. S., de Macedo, R. C., de Almeida, L. A. B., & dos Santos, C. P. C. (2023) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfex.v21i4.5379
Advanced therapeutics for targeting inflammatory arthritis
Singh, V. J., Chawla, P. A., Kumar, B., & Prasher, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00003-6
Glutathione Precursors Supplementation Effects on Renal Function, Lipid Profile and Body Composition
Basri, N. R. H., Mohktar, M. S., Zaman, W. S. W. K., & Rengasamy, S. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-56438-3_6
A PATIENT WITH OSTEOARTHRITIS AND HYPERTENSION IN GENERAL MEDICAL PRACTICE
Ждан, В. М., Lebid, V. G., & Kyrian, O. A. (2024) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.24.3.156
An integrative approach towards understanding metabolic regulation in osteoarthritis
Wu, X. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.249236
Lu, C., Si, Y., Pan, Y., Wang, L., Liu, M., Chen, S., Shi, L., Zhao, R., Li, Z., Yang, G., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7556233/v1
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726081
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726096
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726084
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726087
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726090
Liu, W., Wu, Y., Ma, R., Zhu, X., Wang, R., He, L., & 舒茂国 (2024) · Figshare · doi:10.6084/m9.figshare.26726093
\nRadical Metabolism: Is Cholesterol Inflaming Osteoarthritis?
Kruisbergen, N. N. L. (2023) · Radboud Repository (Radboud University)
The Association Between Serum Lipoproteins and Osteoarthritis in the Elderly People
Noh, H., & Kim, B.-G. (2026) · 대한구강악안면병리학회지 · doi:10.17779/kaomp.2026.50.1.002
Xue, C., Kui, W., Li, X., Li, L., Song, L., Mao, D., Speakman, J. R., Qin, L., Tong, L., & Chen, D. (2026) · Life Medicine · doi:10.1093/lifemedi/lnag029
Metabolic checkpoints in bone remodeling: from dysregulation to targeted therapies
Xuequan, Z., Han, X., Wang, B., Gao, W., & Zhang, Z. (2026) · Clinics · doi:10.1016/j.clinsp.2026.101060
Metadata
- Authors
- Farnaghi, S., Prasadam, I., Cai, G., Friis, T., Du, Z., Crawford, R., Mao, X., & Xiao, Y.
- Affiliations
- Institute of Health and Biomedical Innovation School of Chemistry, Physics, and Mechanical Engineering
- Central South University (CN)
- Prince Charles Hospital (AU)
- Queensland University of Technology (AU)
- Corresponding author
- Mao, Xinzhan
- Xiao, Yin
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2016-10-13
- Volume
- 31
- Issue
- 1
- Pages
- 356-367
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2530698099
- Cited by
- 112
- References
- 41
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 15 · 2019: 4 · 2018: 6 · 2017: 8
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hospital Research Foundation (MS2014- 12)
- National Natural Science Foundation of China (81371997)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone and Joint Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- osteoarthritis, hypercholesterolemia, mitochondrial dysfunction, mitochondria-targeted antioxidants, statins, atorvastatin, reactive oxygen species, chondrocytes, cartilage degeneration, extracellular matrix, oxidative stress, apoptosis, free cholesterol, proteoglycan loss, osteophyte formation
- MeSH terms
- Atorvastatin, Animals, Anticholesteremic Agents, Antioxidants, Apolipoproteins E, Cholesterol, Dietary Fats, Hypercholesterolemia, Male, Mitochondria, Osteoarthritis, Bone Remodeling, Rats, Wistar, Mice, Knockout, Chondrocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.